VolitionRx Files New Patent Protecting its Nu.Q® NETs Test for Ebola Triage and Treatment Monitoring

Patent ExpiryNu.Q® NETs TestPositive

AI Analysis

Summary

VolitionRx announced the filing of a new patent protecting its Nu.Q® NETs Test for Ebola triage and treatment monitoring. The company is seeking strategic partners to deploy the Nu.Q® platform in outbreak zones.

Importance:4/10

Sentiment:

0.30

intellectual propertypatent filingdiagnostic testinfectious diseasepartnership seeking

Related Companies

$VNRX

Read the original article

Published by PR Newswire Biotech on June 3, 2026 12:12 PM

Read Original